Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System
NCT ID: NCT04014933
Last Updated: 2023-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
44 participants
OBSERVATIONAL
2019-07-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Blood Flow Regulation With Laser Speckle Flowgraphy
NCT03391518
Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects
NCT03870230
LSFG in Patients With Normal Tension Glaucoma Tension Glaucoma
NCT03318510
Evaluation of Blood Flow Characteristics in Glaucoma Using Optical Coherence Tomography Angiography (OCT-A).
NCT02757677
Choroidal Blood Flow Response to Hand-grip Test in Progressive Glaucoma
NCT00284440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In order to measure the peripapillary blood flow a variety of devices using different techniques of flowmetry have been developed. In this study, the reproducibility of the retinal flowmetry measured with the LSFG-NAVI device from Nidek will be investigated. A high reproducibility is crucial for the clinical value of any measuring device.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
open-angle glaucoma
patients with a diagnosis of open-angle glaucoma, i.e. untreated IOP \>21mmHg plus glaucomatous disc changes and/or visual field defects typical for glaucoma
LASER SPECKLE FLOWGRAPHY
Non-invasive, real-time imaging and measurement of ocular blood flow of the optic disc and peripapillary region
normal tension glaucoma
patients with a diagnosis of normal tension glaucoma, i.e. untreated IOP \</=21mmHg plus glaucomatous disc changes and/or visual field defects typical for glaucoma
LASER SPECKLE FLOWGRAPHY
Non-invasive, real-time imaging and measurement of ocular blood flow of the optic disc and peripapillary region
healthy controls
individuals with normal optic disc and IOP \</21mmHg and normal visual fields
LASER SPECKLE FLOWGRAPHY
Non-invasive, real-time imaging and measurement of ocular blood flow of the optic disc and peripapillary region
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LASER SPECKLE FLOWGRAPHY
Non-invasive, real-time imaging and measurement of ocular blood flow of the optic disc and peripapillary region
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be at least 18 years old
* Diagnosis of primary or secondary open-angle glaucoma or normal tension glaucoma or healthy controls
Exclusion Criteria
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
* No vulnerable participants will be included in this study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marc Töteberg-Harms, MD, FEBO
Role: PRINCIPAL_INVESTIGATOR
UniversityHospital Zurich, Department of Ophthalmology, Zurich, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ophthalmology
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LSFG Repro
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.